Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile

Journal of Critical Care

Volumn 32, Issue , 2016, Pages 9-15

  Tsirigotis, Panagiotis ^a   Chondropoulos, Spiros ^a   Frantzeskaki, Frantzeska ^a   Stamouli, Maria ^a   Gkirkas, Konstantinos ^a   Bartzeliotou, Anastasia ^b   Papanikolaou, Nikolaos ^a   Atta, Maria ^a   Papassotiriou, Ioannis ^b   Dimitriadis, George ^a   Dimopoulou, Ioanna ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Endothelium; ICAM; IL 8; Sepsis; SuPAR; Thrombocytopenia

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE; INTERLEUKIN 8; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; VASCULAR CELL ADHESION MOLECULE; BIOLOGICAL MARKER; IL8 PROTEIN, HUMAN;

ADULT; AGED; APACHE; ARTICLE; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VERY ELDERLY; BLOOD; COMPLICATION; CRITICAL ILLNESS; EPIDEMIOLOGY; GREECE; HOSPITAL MORTALITY; INCIDENCE; INTENSIVE CARE; MIDDLE AGED;

ADULT; AGED; BIOMARKERS; CRITICAL CARE; CRITICAL ILLNESS; CYTOKINES; FEMALE; GREECE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTERLEUKIN-8; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; ROC CURVE; SEPSIS; THROMBOCYTOPENIA;

EID: 84959497322     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2015.11.010     Document Type: Article

References (31)

1. Thiele T., Selleng K., Selleng S., Greinacher A., Bakchoul T. Thrombocytopenia in the intensive care unit-diagnostic approach and management. Semin Hematol 2013, 50(3):239-250.
2. Levi M., Löwenberg E.C. Thrombocytopenia in critically ill patients. Semin Thromb Hemost 2008, 34(5):417-424.
3. Vanderschueren S., De Weerdt A., Malbrain M., Vankersschaever D., Frans E., Wilmer A., et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000, 28(6):1871-1876.
4. Crowther M.A., Cook D., Meade M., Griffith L., Guyatt G., Arnold D., et al. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005, 20(4):348-353.
5. Kellum J.A., Kong L., Fink M.P., Weissfeld L.A., Yealy D.M., Pinsky M.R., et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167(15):1655-1663.
6. Fjell C., Thair S., Hsu J., Walley K., Russell J., Boyd J. Cytokines and signaling molecules predict clinical outcomes in sepsis. PLoS One 2013, 8(11):e79207.
7. Thuno M., Macho B., Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009, 27(3):157-172.
8. Donadello K., Scolletta S., Covajes C., Vincent J.L. suPAR as a prognostic biomarker in sepsis. BMC Med 2012, 10:2.
9. Steyers C., Miller F. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci 2014, 15(7):11324-11349.
10. Yu H., Huang X., Ma Y., Gao M., Wang O., Gao T., et al. Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions. Int J Biol Sci 2013, 9(9):966-979.
11. Angus D.C., van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013, 369(9):840-851.
12. LeGall J.R., Loirat P., Alperovitch A. APACHE II-a severity of disease classification system. Crit Care Med 1986, 14(8):754-755.
13. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22(7):707-710.
14. Greinacher A., Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program 2010, 135-143.
15. Vandijck D.M., Blot S.I., De Waele J.J., Hoste E.A., Vandewoude K.H., Decruyenaere J.M. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung 2010, 39(1):21-26.
16. Brogly N., Devos P., Boussekey N., Georges H., Chiche A., Leroy O. Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect 2007, 55(2):136-140.
17. Hui P., Cook D.J., Lim W., Fraser G.A., Arnold D.M. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 2011, 139(2):271-278.
18. Martin C.M., Priestap F., Fisher H., Fowler R.A., Heyland D.K., Keenan S.P., et al. A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med 2009, 37(1):81-88.
19. Thiolliere F., Serre-Sapin A., Reignier J., Benedit M., Constantin J.-M., Lebert C., et al. Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study. Intensive Care Med 2013, 39(8):1460-1468.
20. Levi M., Toh C.H., Thachil J., Watson H.G. Guidelines for the diagnosis and management of disseminated intravascular coagulation. Br J Haematol 2009, 145(1):24-33.
21. Endemann D., Schiffrin E. Endothelial dysfunction. J Am Soc Nephrol 2004, 15(8):1983-1992.
22. Schouten M., Wiersinga W., Levi M., van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008, 83(3):536-545.
23. Presterl E., Staudinger T., Pettermann M., Lassnigg A., Burgmann H., Winkler S., et al. Cytokine profile and correlation to the APACHE III and MPM II score in patients with sepsis. Am J Respir Crit Care Med 1997, 156(3):825-832.
24. Oberholzer A., Souza S.M., Tschoeke S.K., Oberholzer C., Abouhamze A., Pribble J.P., et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005, 23(6):488-493.
25. Rodríguez-Gaspar M., Santolaria F., Jarque-López A., González-Reimers E., Milena A., de la Vega M.J., et al. Prognostic value of cytokines in SIRS general medical patients. Cytokine 2001, 15(4):232-236.
26. Bozza F., Salluh J., Japiassu A., Soares M., Assis E.F., Gomes R.N., et al. Cytokine profiles as markers of disease activity in sepsis: a multiplex analysis. Crit Care 2007, 11(2):R49.
27. Giamarellos-Bourboulis E., Norrby-Teglund A., Mylona V., Savva A., Tsangaris I., Dimopoulou I., et al. Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor. Crit Care 2012, 16(4):R149.
28. Backes Y., van der Sluijs K., Mackie D., Tacke F., Koch A., Tenhunen J., et al. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med 2012, 38(9):1418-1428.
29. Gustafsson A., Ljunggren L., Bodelsson M., Berkestedt I. The prognostic value of suPAR compared to other inflammatory markers in patients with severe sepsis. Biomark Insights 2012, 7:39-44.
30. Koch A., Voigt S., Kruschinski C., Sanson E., Dückers H., Horn A., et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2012, 15(1):R63.
31. Boomer J., Green J., Hotchkiss R. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?. Virulence 2014, 5(1):45-56.